Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ELETRIPTAN HYDROBROMIDE Cause Disease recurrence? 5 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Disease recurrence have been filed in association with ELETRIPTAN HYDROBROMIDE (Eletriptan hydrobromide). This represents 0.2% of all adverse event reports for ELETRIPTAN HYDROBROMIDE.

5
Reports of Disease recurrence with ELETRIPTAN HYDROBROMIDE
0.2%
of all ELETRIPTAN HYDROBROMIDE reports
0
Deaths
3
Hospitalizations

How Dangerous Is Disease recurrence From ELETRIPTAN HYDROBROMIDE?

Of the 5 reports, 3 (60.0%) required hospitalization.

Is Disease recurrence Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ELETRIPTAN HYDROBROMIDE. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does ELETRIPTAN HYDROBROMIDE Cause?

Drug ineffective (502) Migraine (310) Headache (246) Malaise (143) Nausea (127) Pain (116) Recalled product administered (115) Vomiting (110) Off label use (106) Condition aggravated (91)

What Other Drugs Cause Disease recurrence?

NIRMATRELVIR\RITONAVIR (20,040) PREDNISONE (1,979) CYCLOPHOSPHAMIDE (1,689) RITUXIMAB (1,588) METHOTREXATE (1,401) DOXORUBICIN (980) VINCRISTINE (932) PREDNISOLONE (873) MYCOPHENOLATE MOFETIL (852) DEXAMETHASONE (784)

Which ELETRIPTAN HYDROBROMIDE Alternatives Have Lower Disease recurrence Risk?

ELETRIPTAN HYDROBROMIDE vs ELEXACAFTOR\IVACAFTOR\TEZACAFTOR ELETRIPTAN HYDROBROMIDE vs ELIGLUSTAT ELETRIPTAN HYDROBROMIDE vs ELIQUIS ELETRIPTAN HYDROBROMIDE vs ELOSULFASE ALFA ELETRIPTAN HYDROBROMIDE vs ELOTUZUMAB

Related Pages

ELETRIPTAN HYDROBROMIDE Full Profile All Disease recurrence Reports All Drugs Causing Disease recurrence ELETRIPTAN HYDROBROMIDE Demographics